îæ€çŽ¢
îæ€çŽ¢
î
ATAI Life Sciences NV
ATAIîãŠã©ãããªã¹ãã«è¿œå
4.880USD
-0.390-7.40%
çµå€Â 07/01, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
1.80Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-01ATAI Life Sciences NVã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.43ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž125äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯12.00ã§ãæé«ã¯16.00ãæäœã¯7.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
15
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
13.833
ç®æšæ ªäŸ¡
+162.49%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
562
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
ATAI Life Sciences NV
ATAI
15
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
ATAI Life Sciences NV ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îATAI Life Sciences NV ã®äºæ³åç㯠11.11K ã§ãã
ATAI Life Sciences NV ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãATAI Life Sciences NV ã®ç®æšæ ªäŸ¡ã USD 12.00 ãšäºæ³ããæé«äºæ³ã¯ USD 16.00ãæäœäºæ³ã¯ USD 7.00 ãšäºæ³ããŠããŸãã
ATAI Life Sciences NVATAI ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.08 ã§ããããATAI Life Sciences NVATAI ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -1.73 ã§ããã次ã®ååæã® EPS 㯠USD -0.10 ãšäºæ³ãããŸãã
ATAI Life Sciences NV ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î15 ã¢ããªã¹ãã«ãã ATAI Life Sciences NV æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« ATAI Life Sciences NV ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã